PathoVax LLC is a Johns Hopkins start-up biotechnology company headquartered in Baltimore, Maryland. Founded in 2014, the company has been focused on different medical applications for its proprietary Papillomavirus Virus-like Particle (VLP) platform.
Management & Operations Team
Dr Wang trained in Papillomavirus VLPs at Johns Hopkins University. Prior to founding PathoVax, Joshua explored opportunities in innovation and venture creation at Flagship Ventures (now Flagship Pioneering).
Joshua Wang Ph.D.
Co-Founder & CEO
Dr Lai has more than 20 years’ of CMC operational experience in bio-pharmaceutical and healthcare start-ups.
Wen Bin obtained her Ph.D. from the University of Cambridge and received her MBA from the Singapore Management University, where she graduated as valedictorian.
Wenbin Lai Ph.D., MBA
Chemistry, Manufacturing & Controls Advisor (Singapore)
Dr Robert (‘”Bob”) Becker, PhD MBA is an experienced executive with a proven history in fostering partnerships with product development, cGMP manufacturing, clinical development and regulatory affairs
Robert "Bob" Becker Ph.D., MBA
Business Management
Mr Jay Nadkarni joins PathoVax with 20+ years of experience in all aspects of new product commercialization and licensing; and has to his credit many successful licensing deals brought to fruition. He has a commendable track record in Innovation Management, Licensing, Business Development, and Technology Transfers for Biopharmaceuticals, Biologics, and Rx / OTC Pharmaceuticals all over the world with emphasis on Tier-1&2 Emerging Markets
Jay Nadkarni, MBA
Partnerships
Business Advisory Board
Robert Silverman
Chairman of Business Advisory Board
Eric Richman, MBA
Business Advisor
Roger Pomerantz M.D., FACP
Business Advisor
Solomon Langermann, Ph.D
Business Advisor
Scientific, Clinical Advisory Board, and Collaborators
Richard Roden, Ph.D
Co-director of Viral Oncology, Johns Hopkins School of medicine
Reinhard Kirnbauer, MD
Director of Viral Oncology,
Medical University Vienna
Warner Huh, M.D
Professor and Division Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham.
